1. Bamlanivimab and etesevimab for post-exposure prophylaxis of COVID-19.;Med Lett Drugs Ther,2021
2. Casirivimab and imdevimab (REGEN-COV) for post-exposure prophylaxis of COVID-19.;Med Lett Drugs Ther,2021
3. In brief: third dose of mRNA-based COVID-19 vaccines for immunocompromised persons.;Med Lett Drugs Ther,2021
4. Booster doses of COVID-19 vaccines.;Med Lett Drugs Ther,2021
5. Coronavirus (COVID-19) update: FDA authorizes new long-acting monoclonal antibodies for pre-exposure prevention of COVID-19 in certain individuals. News release. US Food and Drug Administration; December 8, 2021. Accessed December 16, 2021. https://bit.ly/3saed1U